Дазатиниб - analogs
Components: Dasatinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Дазатиниб | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Raltitrexed ✘ (incl) Pentoxifylline-Akri ✘ (incl) Ацикловир Дж ✘ (incl) Campto ✘ (incl) Bicalutamide Sandoz ✘ (incl) Valacyclovir-OBL ✘ (incl) Polypeptides from the brain of pig embryos ✘ (incl) Mesulfamide+Peppermint Leaf Oil+Sulfathiazole+Thymol+Eucalyptus Ball Leaf Oil ✘ (incl) Tinctura Schizandrae chinensis ✘ (incl) Menthae piperitae folia ✘ (incl) Threonine ✘ (incl) Biovital Vitamin C 500 ✘ (incl) Novocainamide ✘ (incl) КОМПЛИВИТ АКТИВные Мишки ✘ (incl) Пустырник П драже ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Sprycel neutral | 1388.4€ |
≈100% | Dasatinib-nativ neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 72% — Lanvis Negative 🔍 [Tioguanine]
- 70% 229.9-1149.4€ Bosulif neutral [Bosutinib]
- 69% — Nilotinib-nativ neutral [Nilotinib]
- 69% 1920€ Tasigna neutral [Nilotinib]
- 69% — Nilotinib hydrochloride monohydrate neutral [Nilotinib]
- 69% — Нилотиниб neutral [Nilotinib]
- 67% — Калквенс neutral [Akalabrutinib]
- 57% 115€ Vidaza Negative 🔍 [Azacitidine]
- 56% — Gistamel Dangerous 🔍 [Imatinib]
- 56% — Imatinib-Alvogen Dangerous 🔍 [Imatinib]
- 56% — Imagliv Dangerous 🔍 [Imatinib]
- 56% — Citonib Dangerous 🔍 [Imatinib]
- 56% — Imatinib-Actavis Dangerous 🔍 [Imatinib]
- 56% — Imatinib medac Dangerous 🔍 [Imatinib]
- 56% — Iimatinib mesilate Dangerous 🔍 [Imatinib]
- 56% 324.5€ Иглиб Dangerous 🔍 [Imatinib]
- 54% 8.3€ Puri-Nethol Negative 🔍 [Mercaptopurine]
- 54% 6.7-7.4€ Mercaptopurin Negative 🔍 [Mercaptopurine]
- 54% — Меркаптопурина моногидрат Negative 🔍 [Mercaptopurine]
- 54% — Mercaptopurin-nativ Negative 🔍 [Mercaptopurine]
- 54% — Mercaptopurine tablets Negative 🔍 [Mercaptopurine]
- 54% — Imvec Dangerous 🔍 [Imatinib]
- 54% 605€ Imatib Dangerous 🔍 [Imatinib]
- 54% — Цитонибонко Dangerous 🔍 [Imatinib]
- 54% — Imatinib-Teva Dangerous 🔍 [Imatinib]
- 54% — Imatinib Grindex Dangerous 🔍 [Imatinib]
- 54% — Imatinib Dr. Reddy s Dangerous 🔍 [Imatinib]
- 54% — Глемихиб Dangerous 🔍 [Imatinib]
- 52% 271€ Neopax Dangerous 🔍 [Imatinib]
- 52% 4850€ Imbruvica neutral [Ibrutinib]
- 52% — Imatinib-TL Dangerous 🔍 [Imatinib]
- 47% 48.7€ Philachromin Dangerous 🔍 [Imatinib]
- 46% — Genfatinib Dangerous 🔍 [Imatinib]
- 45% 73.4€ Venclexta neutral [Venetoclax]
- 45% — Idarubicin Positive 🔍 [Idarubicin]
- 45% 445.1€ Lonquex No 🔍 [Lipegfilgrastim and more 1Proteine]
- 45% 30€ Zavedos Positive 🔍 [Idarubicin]
- 45% — Idarubicin hydrochloride Positive 🔍 [Idarubicin]
- 45% — Неларабин Negative 🔍 [Nelarabine]
- 45% 630€ Atriance Negative 🔍 [Nelarabine]
- 45% — Idalek Positive 🔍 [Idarubicin]
- 45% 2957.2€ Lemtrada neutral [Alemtuzumab]
- 44% — Neitrostim Negative 🔍 [Filgrastim]
- 44% 17.4€ Cytarabin-LANS Negative 🔍 [Cytarabine]
- 44% 6.1-7.6€ Cytosar Negative 🔍 [Cytarabine]
- 44% — Cytastadine Negative 🔍 [Cytarabine]
- 44% — Цитозар НоваМедика Negative 🔍 [Cytarabine]
- 44% — Цитарабин-рус Negative 🔍 [Cytarabine]
- 44% 25.9-28.6€ Neupogen Negative 🔍 [Filgrastim]
- 44% — Иматиниб-Сигардис Dangerous 🔍 [Imatinib]
Learn more about the selection of analogues
- The drug has «Дазатиниб» 4 full analogs, the cheapest - Sprycel (1388.4€); 51 analog by action, the most similar - Bosulif (229.9-1149.4€).
- Medical online service has selected the best substitutes for Дазатиниб based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Дазатиниб analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.